Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1–42 in Alzheimer’s disease

Scheltens, P. et al. Alzheimer’s disease. Lancet 397, 1577–1590. https://doi.org/10.1016/S0140-6736(20)32205-4 (2021).

Article 
CAS 

Google Scholar 

Hampel, H. et al. The amyloid-beta pathway in Alzheimer’s disease. Mol. Psychiatry https://doi.org/10.1038/s41380-021-01249-0 (2021).

Article 

Google Scholar 

Hardy, J. & Allsop, D. Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol. Sci. 12, 383–388 (1991).

Article 
CAS 

Google Scholar 

Selkoe, D. J. & Hardy, J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol. Med. 8, 595–608. https://doi.org/10.15252/emmm.201606210 (2016).

Article 
CAS 

Google Scholar 

Maloney, B. & Lahiri, D….